chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Headache, Neck pain
Clinical narrative: body aches; neck ache; joint pains; Fatigue; moderate-severe headache; low fever; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: ER8732) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included Paget Schroetter -blood clot - right 1st rib resection from 2007 to 2009. The patient was allergic to sulphites, penicillin, quinolones, sulfanamide clarithromycin(UNKNOWN MANUFACTURER) and septocaine(UNKNOWN MANUFACTURER) . Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient was not tested for COVID-19. On 25Mar2021 at 12:15, the patient experienced fatigue, moderate-severe headache, low fever 99.5F, neck/body aches and joint pains. The patient did not receive any treatment for the reported events. The clinical outcome of the events fatigue, moderate-severe headache, low fever, neck/body aches and joint pains were recovering at the time of this report.    No follow-up attempts possible. No further information expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: body aches; neck ache; joint pains; Fatigue; moderate-severe headache; low fever; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: ER8732) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included Paget Schroetter -blood clot - right 1st rib resection from 2007 to 2009. The patient was allergic to sulphites, penicillin, quinolones, sulfanamide clarithromycin(UNKNOWN MANUFACTURER) and septocaine(UNKNOWN MANUFACTURER) . Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient was not tested for COVID-19. On 25Mar2021 at 12:15, the patient experienced fatigue, moderate-severe headache, low fever 99.5F, neck/body aches and joint pains. The patient did not receive any treatment for the reported events. The clinical outcome of the events fatigue, moderate-severe headache, low fever, neck/body aches and joint pains were recovering at the time of this report.    No follow-up attempts possible. No further information expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Palpitations
Clinical narrative: Heart racing in first two hoursTightness in chest ; like someone was squeezing my hear/middle of chest; Tightness in chest ; like someone was squeezing my hear/middle of chest; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in left arm on 17Mar2021 at 15:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had pollen allergy. Concomitant medications and medical history was not been reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The patient experienced heart racing in first two hours and tightness in chest on 17Mar2021 at 16:00. The patient received treatment with zyrtec and albuterol for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The outcome of the events heart racing and tightness in chest were recovered in Mar2021.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Rash pruritic
Clinical narrative: Extensive itchy rash over entire trunk, back and front, including around legs at pubic area.; feeling of unwellness.; This is a spontaneous report received from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 14:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient medical history included COVID-19 and rash after the first shingles vaccine. The patient did not receive any medications within 2 weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021, the patient had extensive itchy rash over entire trunk, back and front, including around legs at pubic area and accompanied by slight feeling of unwellness. It was reported that no treatment measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of extensive itchy rash and feeling of unwellness was recovered on an unspecified date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Allergy to vaccine, Fatigue, Lethargy, Rash
Clinical narrative: Extensive itchy rash over entire trunk, back and front, including around legs at pubic area.; feeling of unwellness.; This is a spontaneous report received from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 14:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient medical history included COVID-19 and rash after the first shingles vaccine. The patient did not receive any medications within 2 weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021, the patient had extensive itchy rash over entire trunk, back and front, including around legs at pubic area and accompanied by slight feeling of unwellness. It was reported that no treatment measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of extensive itchy rash and feeling of unwellness was recovered on an unspecified date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Inappropriate schedule of product administration, Pain, Somnolence
Clinical narrative: This is a spontaneous report received from a non-contactable consumer, the patient. A 47-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to food, medications, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 12Mar2021 at 09:30 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 17:00, the patient experienced extreme fatigue and ache for at least 24 hours and counting. Being sleeping all day. The patient received first dose on 12Mar2021 and second dose on 29Mar2021 (inappropriate schedule of vaccine administration). The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events extreme fatigue, ache and sleepy were resolving at the time of reporting and the clinical outcome of inappropriate schedule of vaccine administered was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Lip swelling, Pharyngeal swelling
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8732) via unspecified route of administration in the left arm on 26Mar2021 at 13:11 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medication within 2 weeks of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 13:28, 17 minutes after shot received, the patient experienced very slight lips swell (both top and bottom), not visible but felt to the patient; slight throat swell on left side, not visible, but felt to the patient and chest a little heavy/slight air restriction, not much, like when the oxygen is reduced in the room when too much bleach is used and a window needs to be opened. No therapeutic measures were taken as a result of the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lip swelling, pharyngeal swelling and chest discomfort were recovered on 26Mar2021 at 14:08.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Small rash, first on palm of right hand, then on back of left hand on an old scar; This is a spontaneous report from a contactable consumer, the patient. A 41-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 12Mar2021 at 16:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history, and did not have any known allergies. The patients concomitant medications were not reported. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date (at an unknown age) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021 at 06:00, the patient experienced small rash, first on palm of right hand, then on back of left hand on an old scar. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event small rash was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Night sweats
Clinical narrative: floppy night sweats; periodic sweats during the day; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 25Mar2021 at 17:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic, pulmonary embolism and HBP (high blood pressure). Concomitant medications included doxazosin mesilate (CARDURA), triamterene (MANUFACTURER UNKNOWN), montelukast sodium (SINGULAIR) and low dose aspirin (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates. The patient previously took lisinopril (ZESTRIL) and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26Mar2021 (conflictingly reported as after seven days), the patient experienced floppy night sweats and periodic sweats during the day. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events night sweats and sweating. The clinical outcomes of the events night sweats and sweating were recovering at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: U
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: SEVERE MIGRANE HEADACHE; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) on an unknown date in Mar2021 at 07:30 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. The patient was not aware of any known allergies to medications, food or other products. The patient had no concomitant medications received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6199) on an unknown date in Mar2021 at 08:00 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 06:00, the patient experienced severe migraine headache 3 days in a row after receiving the second dose of vaccine and the patient remained in bed in the dark room for 3 days. Treatment was not taken as a result of migraine headache. The clinical outcome of the event migraine headache was not recovered.   No follow-up attempts possible. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Paraesthesia oral, Pruritus, Pyrexia
Clinical narrative: chills; fever; runny nose; tired; itching at arm; Over the next week the itching got worst covering my whole body; tingled lips; tingling mouth; This is a spontaneous report from a contactable other healthcare professional, the patient. A 53-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration in the left arm on 20Mar2021 at 09:000 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. The patient's medical history included diabetes and the patient was allergic to seafood and shrimps. Concomitant medications included metformin (1000mg) (MANUFACTURER UNKNOWN) and furosemide sodium (20mg) (LASIX) both from unknown dates for unspecified indications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination the patient had not been tested for COVID-19 and since the vaccination, the patient was not tested for COVID-19. On the same day 20Mar2021 at 10:00, the patient experienced, by the time the patient reached the car, that her arm was itching badly. The patient wasn't alarmed, and thought it would eventually pass. The itching continued off and on to the next day on 21Mar2021 and the patient experienced chills, runny nose, fever and felt very tired. Over the next week on unknown date in Mar2021, the itching got worse, covered whole body, and was like a burning sensation that started on the back and throughout the body, even on hands and the bottom of feet. The lips and mouth tingled too. The event resulted in, doctor or other healthcare professional office or clinic visit and started to feel normal again. Therapeutic measures were taken for the reported events and treatment included with Hydroxzine (25mg) and Zyrtec (10mg). The clinical outcome of itching at arm and itching at whole body continuing by hands, back and feet and chills, fever, runny nose, tiredness, tingling lips and tingling mouth was recovering, at this time of report.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: chills; fever; runny nose; tired; itching at arm; Over the next week the itching got worst covering my whole body; tingled lips; tingling mouth; This is a spontaneous report from a contactable other healthcare professional, the patient. A 53-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration in the left arm on 20Mar2021 at 09:000 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. The patient's medical history included diabetes and the patient was allergic to seafood and shrimps. Concomitant medications included metformin (1000mg) (MANUFACTURER UNKNOWN) and furosemide sodium (20mg) (LASIX) both from unknown dates for unspecified indications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination the patient had not been tested for COVID-19 and since the vaccination, the patient was not tested for COVID-19. On the same day 20Mar2021 at 10:00, the patient experienced, by the time the patient reached the car, that her arm was itching badly. The patient wasn't alarmed, and thought it would eventually pass. The itching continued off and on to the next day on 21Mar2021 and the patient experienced chills, runny nose, fever and felt very tired. Over the next week on unknown date in Mar2021, the itching got worse, covered whole body, and was like a burning sensation that started on the back and throughout the body, even on hands and the bottom of feet. The lips and mouth tingled too. The event resulted in, doctor or other healthcare professional office or clinic visit and started to feel normal again. Therapeutic measures were taken for the reported events and treatment included with Hydroxzine (25mg) and Zyrtec (10mg). The clinical outcome of itching at arm and itching at whole body continuing by hands, back and feet and chills, fever, runny nose, tiredness, tingling lips and tingling mouth was recovering, at this time of report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Lymphadenopathy, Night sweats
Clinical narrative: Fever up to 102.3; chills; night sweats; body aches; headaches; very swollen lymph node under armpit; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included depression and anxiety. The patient did not have allergies to medications, food, or other products. Concomitant medications included duloxetine hydrochloride (CYMBALTA), lorazepam (ATIVAN), paracetamol (TYLENOL), and ibuprofen (MANUFACTURER UNKNOWN) and cyclobenzaprine hydrochloride (FLEXERIL); all from an unknown date for unknown indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 05:00, the patient experienced fever up to 102.3, chills, night sweats, body aches, headaches, very swollen lymph nodes under the armpit. All the symptoms lasted seventy-two hours with the exception of swollen lymph nodes which was on going as of eighty hours. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events fever, night sweats, chills, ache and headache was recovered on 27Mar2021 with lasting effects; while that of axillary adenopathy was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever up to 102.3; chills; night sweats; body aches; headaches; very swollen lymph node under armpit; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included depression and anxiety. The patient did not have allergies to medications, food, or other products. Concomitant medications included duloxetine hydrochloride (CYMBALTA), lorazepam (ATIVAN), paracetamol (TYLENOL), and ibuprofen (MANUFACTURER UNKNOWN) and cyclobenzaprine hydrochloride (FLEXERIL); all from an unknown date for unknown indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 05:00, the patient experienced fever up to 102.3, chills, night sweats, body aches, headaches, very swollen lymph nodes under the armpit. All the symptoms lasted seventy-two hours with the exception of swollen lymph nodes which was on going as of eighty hours. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events fever, night sweats, chills, ache and headache was recovered on 27Mar2021 with lasting effects; while that of axillary adenopathy was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Musculoskeletal chest pain
Clinical narrative: Expired vaccine used; Shingles like pain around left rib cage, no rash.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old adult male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via an unspecified route of administration in the left arm on 07Mar2021 (at the age 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included famotidine (PEPCID AC) and atenolol (MANUFACTURER UNKNOWN), all for unknown indications and from an unknown date and unknown if ongoing. The patient had not received any other vaccine within four weeks of vaccination. Prior to the vaccination, the patient was not tested with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021, the patient experienced shingles like pain on the left rib cage, no rash. The patient never had this type of pain before and expired vaccine was used. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the shingles like pain around the left rib cage which included treatment with unknown antiviral and pain medications. The clinical outcome of shingles like pain around the left rib cage was not recovered, outcome of expired vaccine used was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus, Rash erythematous, Rash pruritic
Clinical narrative: full body rash. Red, very itchy; itchy rash on arms and legs; Itching on right arm at injectionspot; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old, male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on an unknown date (age at vaccination 34-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks of vaccination. On 24Mar2021 at 19:00, the patient experienced itching on right arm at the injection spot. On 25Mar2021, the patient experienced itchy rash on arms and legs. On 26Mar2021 the patient experienced rash into full body and reported it to be red and very itchy. The events resulted in doctor or other healthcare professional office/clinic visit on the sixth day. Therapeutic measures were taken as a result of adverse events it included medicines (unspecified) and the patient reported that the rash was receding. The clinical outcome of the events itching on right arm at injection spot, itchy rash on arms and legs and red very itchy full body rash was resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Oropharyngeal pain, Respiration abnormal
Clinical narrative: Extreme exhaustion; pain at injection site; headache; dizziness; sore throat; Seeing spots; Breath fog; This is a spontaneous report received from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER3789) via an unspecified route of administration in the left arm on 26Mar2021 at 15:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. It was reported that patient received unspecified medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, the patient experienced extreme exhaustion, pain at injection site, headache, dizziness, breath fog, was seeing spots, and sore throat. The adverse events did not result in doctor or other healthcare professional office/clinic visit, or emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events extreme exhaustion, pain at injection site, headache, dizziness, breath fog, seeing spots and sore throat was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vitreous floaters
Clinical narrative: Extreme exhaustion; pain at injection site; headache; dizziness; sore throat; Seeing spots; Breath fog; This is a spontaneous report received from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER3789) via an unspecified route of administration in the left arm on 26Mar2021 at 15:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. It was reported that patient received unspecified medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, the patient experienced extreme exhaustion, pain at injection site, headache, dizziness, breath fog, was seeing spots, and sore throat. The adverse events did not result in doctor or other healthcare professional office/clinic visit, or emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events extreme exhaustion, pain at injection site, headache, dizziness, breath fog, seeing spots and sore throat was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Pain in extremity
Clinical narrative: Flu like; achy arm; chills; This is a spontaneous report received from a non-contactable consumer, the patient. A 56-year-old female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6208) via an unspecified route of administration on the left arm on 15Mar2021 at 15:30 (at the age of 56-years-old), as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 15Mar2021 at 16:30, couple of hours after vaccination, the patient experienced achy arm and chills. On 16Mar2021 (next morning), the patient experienced achy and flu like symptoms for a total of 1.5 days. The clinical outcome of events pain in arm and chills were unknown; while that of flu like symptoms was recovered on an unspecified date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Head discomfort, Headache
Clinical narrative: soreness in left shoulder; soreness in arm; soreness in upper back; headache that feels like pressure; headache that feels likepressure; fatigue; tingling in face; sore swollen lymph nodes on left sideof neck; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, obesity, pars planitis (eyes). The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient had not been tested for COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), acetyl salicylic acid (ASPIRIN), paracetamol (TYLENOL), fish oil (MANUFACTURER UNKNOWN), vitamins (MANUFACTURER UNKNOWN). On 12Mar2021 at 23:00, the patient experienced soreness in left shoulder, arm, upper back. headache that feels like pressure plus a tingly spacey feeling in head, fatigue, tingling in face, sore swollen lymph nodes on left side of neck. It was reported that some of effects happened first 3 days and stopped, recurred day 15, day 16, day 18 (today). No therapeutic measures were taken for the reported events. The events did not result in doctor's or other healthcare professional office/clinic visit. The clinical outcome of the events soreness in left shoulder, arm, upper back, headache that feels like pressure plus a tingly spacey feeling in head, fatigue, tingling in face, sore swollen lymph nodes on left side of neck were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity, Paraesthesia
Clinical narrative: soreness in left shoulder; soreness in arm; soreness in upper back; headache that feels like pressure; headache that feels likepressure; fatigue; tingling in face; sore swollen lymph nodes on left sideof neck; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, obesity, pars planitis (eyes). The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient had not been tested for COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), acetyl salicylic acid (ASPIRIN), paracetamol (TYLENOL), fish oil (MANUFACTURER UNKNOWN), vitamins (MANUFACTURER UNKNOWN). On 12Mar2021 at 23:00, the patient experienced soreness in left shoulder, arm, upper back. headache that feels like pressure plus a tingly spacey feeling in head, fatigue, tingling in face, sore swollen lymph nodes on left side of neck. It was reported that some of effects happened first 3 days and stopped, recurred day 15, day 16, day 18 (today). No therapeutic measures were taken for the reported events. The events did not result in doctor's or other healthcare professional office/clinic visit. The clinical outcome of the events soreness in left shoulder, arm, upper back, headache that feels like pressure plus a tingly spacey feeling in head, fatigue, tingling in face, sore swollen lymph nodes on left side of neck were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Severely swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) via an unspecified route of administration in the left arm on 23Mar2021 at 13:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) via an unspecified route of administration in the left arm on 02Mar2021 at 13:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. On 25Mar2021 at 15:00, three days after the second dose patient had severely swollen lymph nodes. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event severely swollen lymph nodes was not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Headache, Musculoskeletal chest pain, Myalgia
Clinical narrative: extremely painful ribcage, shoulder blades and collar bones; extremely painful ribcage, shoulder blades and collar bones; sore neck and muscles; Bad headache; painful injection site; extremely painful ribcage, shoulder blades and collar bones; sore neck and muscles; This is a spontaneous report from a non-contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the left arm on 26Mar2021 on 11:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 02Mar2021 at 15:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26Mar2021 at 19:00, the patient had bad headache, painful injection site, extremely painful ribcage, shoulder blades and collar bones and sore neck and muscles. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events bad headache, painful injection site, extremely painful ribcage, shoulder blades and collar bones and sore neck and muscles. The clinical outcomes of the events bone pain, rib pain, neck pain, headache, vaccination site pain, shoulder blade pain and muscle soreness were recovering at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Vaccination site pain
Clinical narrative: extremely painful ribcage, shoulder blades and collar bones; extremely painful ribcage, shoulder blades and collar bones; sore neck and muscles; Bad headache; painful injection site; extremely painful ribcage, shoulder blades and collar bones; sore neck and muscles; This is a spontaneous report from a non-contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the left arm on 26Mar2021 on 11:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 02Mar2021 at 15:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26Mar2021 at 19:00, the patient had bad headache, painful injection site, extremely painful ribcage, shoulder blades and collar bones and sore neck and muscles. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events bad headache, painful injection site, extremely painful ribcage, shoulder blades and collar bones and sore neck and muscles. The clinical outcomes of the events bone pain, rib pain, neck pain, headache, vaccination site pain, shoulder blade pain and muscle soreness were recovering at the time of the report.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Grip strength decreased, Vaccination site pain
Clinical narrative: extreme pain in the elbow joint; extreme pain; part of the injected arm with increased pain when trying to grip and pick up objects; increased pain when trying to grip and pick up objects/ability to pick up objects has been impaired due to level of pain; This is a spontaneous report from a non-contactable consumer (patient). An adult female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: PPSZER C-1a EN6205, expiry date unknown), via an unspecified route of administration, administered in the left arm on 03Mar2021 at 10:30, dose 1 single for COVID-19 immunization. The patient did not have any medical history. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On Mar2021 (reported as 2 days after the injection), the patient experienced extreme pain in the elbow joint and lower part of the injected arm with increased pain when trying to grip and pick up objects. It's been over 3 weeks since the vaccine and the pain has gotten worse and the ability to pick up objects has been impaired due to level of pain. The events resulted in a doctor or other healthcare professional office/clinic visit. The patient received treatment (unspecified) for the events. The outcome of the events was not recovered  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Somnolence, Vaccination site pain, Vaccination site rash
Clinical narrative: Injection site was sensitive to touch; Light to moderate light-headednessafter the vaccine; Arrived home, laid down semi upright, and slept for 5 hour and sleeping for extended long periods of time; Ongoing fatigue; Small rash at the vaccine site; This is a spontaneous report received from a contactable consumer, the patient. A 56-years-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in right arm on 12Mar2021 at 09:00 (at the age of 56 years), as a single dose for COVID-19 immunisation. The patient medical history included type1 diabetes, rheumatoid arthritis and psoriatic arthritis since unknown dates. The patient was allergic to penicillin. The patient received secukinumab (COSENTYX) for an unknown indication and from unknown start date. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 09:30 after the vaccine, the patient experienced light to moderate light-headedness. He arrived home, laid down semi-upright, and slept for 5 hours. On days 2 (13Mar2021), the injection site was sensitive to touch. The patient developed a small rash at the vaccine site, had fatigue and was sleeping for extended long periods of time on unknown dates in Mar2021. Patient did not received any treatment for the events. The clinical outcome of events injection site was sensitive to touch, light to moderate light-headedness, small rash at the vaccine site, fatigue and sleeping for extended long periods of time were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Fluid retention, Pyrexia, Swelling face
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 11:15 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not have a history of allergies to medications, food, or other products. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 11:45, the patient experienced face swelling 30 minutes after receiving vaccine, it lasted for 2 hours and it looked like fluid retention and also the patient experienced a mild fever which lasted for a couple of minutes. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the events mild fever, face swelling and fluid retention was resolved on 30Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Muscle strain, Pain, Pain in extremity
Clinical narrative: It feels like I had pulled a muscle and noticed pain in movement and lack of strength.; Pain in arm; It feels like I had pulled a muscle and noticed pain in movement and lack of strength.; It feels like I had pulled a muscle and noticed pain in movement and lack of strength.; This is a spontaneous report received from a contactable consumer, the patient. A 61-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533), via an unspecified route of administration in the left arm on 23Mar2021 at 18:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications of the patient included atorvastatin (MANUFACTURER UNKNOWN) 20 mg and acetylsalicylic acid (ASPIRIN) low dose for unknown indication from an unknown date. The patient did not have allergies to food, medications, or other products. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, the patient experienced pain in arm, loss of strength, pulled muscle, pain upon movement. The patient reported pain in the left arm which persisted until the day. It felt like he had pulled a muscle and noticed pain in movement and lack of strength and felt like someone had repeatedly punched his upper arm. The pain was persisted for 6 days so far. The patient did not receive treatment for the reported events.  The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain in arm, loss of strength, pulled muscle, pain upon movement was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.